Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancer.
Saved in:
| Title: | Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancer. |
|---|---|
| Authors: | Yong L; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.; Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China., Liu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, 100191, China., Jian WZ; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Cai L; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Bao TY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Liu C; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Gan EZ; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Wang TY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Luo PY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Cao BS; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, 100191, China. caobaoshan0711@aliyun.com., Liu W; Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China. liuwei0023@bjmu.edu.cn., Zhou TY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. tianyanzhou@bjmu.edu.cn. |
| Source: | Acta pharmacologica Sinica [Acta Pharmacol Sin] 2025 Nov; Vol. 46 (11), pp. 3087-3098. Date of Electronic Publication: 2025 Jun 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
